Use of esource in clinical trials

eSource (electronic source) in clinical trials is the initial capture of clinical trial data in an electronic format. In traditional clinical research, investigators record patient data on paper source documents, which is then later manually transcribed into an Electronic Data Capture (EDC) system. eSource eliminates or minimizes this intermediate transcription step by capturing data digitally at the start streamlining trial workflows and also improving data consistency.

Compliance

Health authorities globally have recognized the shift from paper to digital data capture.

In September 2013, the United States Food and Drug Administration (FDA) issued a guidance document titled "Electronic Source Data in Clinical Investigations" to assist sponsors, clinical investigators, and contract research organizations in capturing, reviewing, and retaining electronic source data. The guidance document promotes the capture of source data in electronic form to ensure reliability, quality, and traceability.

The European Medicines Agency (EMA) similarly has provided reflection papers on expectations for electronic source data and data transcribed to electronic data collection tools in clinical trials. Systems capturing eSource data must adhere to guidelines such as Title 21 CFR Part 11 and ALCOA principles (Attributable, Legible, Contemporaneous, Original, and Accurate) to ensure regulatory compliance.

Methods

The term eSource covers various data collection methods:

• Direct Data Capture (DDC): Clinical research coordinators input data directly into specialized eSource software or tablets during a patient visit.
• EHR-to-EDC Integration: The automated extraction of relevant medical histories, laboratory values, or diagnostic reports directly from health system Electronic health record (EHR) platforms into trial databases. This utilizes interoperability standards like Fast Healthcare Interoperability Resources (FHIR).
• Electronic Patient-Reported Outcomes (ePRO) / eCOA: Digital assessments, logs, or symptom diaries are completed directly by trial participants using smartphones, tablets, or web portals.
• Connected medical devices and wearables: The automated transmission of continuous or periodic physiological measurements from sensors directly into the study database.

Operational impact and benefits

The adoption of eSource methodologies provides several measurable operational efficiencies and benefits in clinical research. Traditional clinical trial workflows require research teams to extract, transcribe, and validate patient data from EHRs or paper source documents into EDC systems, a comprehensive process that affects more than half of all trial data elements.

By directly capturing data, eSource reduces transcription errors and removes the need for exhaustive Source Data Verification (SDV) by Clinical Research Associates (CRAs), a process that consumes significant operational resources. Furthermore, data entered electronically is available to sponsors and data managers in an instant, which allows for real-time remote monitoring and a faster decision-making process.

Industry platforms and implementation

Different companies offer software platforms designed to facilitate eSource capture for research sites, sponsors, and Contract Research Organizations (CROs).

Notable companies include:

• Advarra: Provides an integrated eSource and site EDC platform designed for research sites, health systems, and site networks. The software provides direct electronic data capture compliant with 21 CFR Part 11, incorporates a FHIR-based interface for laboratory data ingestion, supports remote monitoring workflows for trial sponsors, and integrates with clinical trial management systems (such as OnCore and Clinical Conductors) to automate administrative and financial workflows.
• Clinical.ly: Provides a cloud-based eSource platform within its Clinical.ly ResearchSuite. The software provides direct point-of-care data capture, protocol-driven template updates for study amendments, automated PHI redaction, time-bounded remote monitoring permissions, and participant tracking tools. The platform is built to comply with 21 CFR Part 11, EU Annex 11, and HIPAA data security guidelines.
• (CRIO) (Clinical Research IO): Offers an integrated eSource, eRegulatory, eConsent, and clinical trial management system (CTMS) solution designed to replace paper-based source documentation. It allows sites to capture data using customized templates simultaneously, transmitting it automatically to review modules to enable real-time access and minimize traditional source data verification.
• RealTime Software Solutions: Offers RealTime-eSource, a cloud-based data capture application designed for research sites, site networks, and contract research organizations (CROs). The software provides direct point-of-care data entry with built-in validation checks, electronic signature workflows, automated data capture from external devices, and integrated audit trail functionality compliant with 21 CFR Part 11 and GDPR requirements.

Challenges

The widespread adoption of eSource does face structural and technical barriers. Research sites frequently manage multiple software platforms mandated by different sponsors, that contributes to login fatigue as well as increased administrative burden. Additionally, integrating disparate EHR systems with specialized clinical research databases remains technically complex due to different data standards, evolving regulatory interpretations, and initial capital costs for validation and staff training.

External links

• FDA Guidance on Electronic Source Data in Clinical Investigations

This article "Use of esource in clinical trials" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Use of esource in clinical trials. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

---